A system that delivers an antioxidant to mitochondria for the treatment of drug-induced liver injury
Mitsue Hibino(Hokkaido University), Yuma Yamada(Hokkaido University), Hideyoshi Harashima(Hokkaido University), Manabu Tokeshi(Hokkaido University), Yoichi Ishitsuka(Unknown), Masatoshi Maeki(Hokkaido University)
Cited by 24
Related Papers
The Polyethyleneglycol Dilemma: Advantage and Disadvantage of PEGylation of Liposomes for Systemic Genes and Nucleic Acids Delivery to Tumors
|Biological and Pharmaceutical Bulletin|2013|479
Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases
|Advanced Drug Delivery Reviews|2008|254
Power of mitochondrial drug delivery systems to produce innovative nanomedicines
|Advanced Drug Delivery Reviews|2020|123
Challenges in Promoting Mitochondrial Transplantation Therapy
|International Journal of Molecular Sciences|2020|106
Mitochondrial delivery of Coenzyme Q10 via systemic administration using a MITO-Porter prevents ischemia/reperfusion injury in the mouse liver
|Journal of Controlled Release|2015|97